Masaharu Mori
Corporate Officer/Principal at Laboratoires OncoTherapy Science France SARL
Masaharu Mori active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Laboratoires OncoTherapy Science France SARL | Corporate Officer/Principal | 2014-09-30 | - |
Career history of Masaharu Mori
Former positions of Masaharu Mori
| Companies | Position | Start | End |
|---|---|---|---|
| ONCOTHERAPY SCIENCE, INC. | Director/Board Member | 2014-08-31 | 2017-02-26 |
| President | 2014-08-31 | 2017-02-26 | |
Immunas Pharma, Inc.
 Immunas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Immunas Pharma, Inc. develops anti-cancer antibody medicines. The company is based in Kawasaki, Japan. Immunas Pharma was acquired by OncoTherapy Science, Inc. on September 30, 2007 for $0.43 million. | Director/Board Member | 2014-11-30 | - |
| President | 2014-11-30 | - | |
Dojin Iyaku-Kako Co., Ltd.
 Dojin Iyaku-Kako Co., Ltd. Pharmaceuticals: MajorHealth Technology Dojin Iyaku-Kaku Co., Ltd. is engaged in the development, production, and distribution of pharmaceutical products and pharmaceutical raw materials. The company was established in 1946 and is based in Tokyo, Japan. | President | 2011-09-25 | - |
Statistics
International
| Japan | 4 |
| France | 2 |
Operational
| President | 3 |
| Director/Board Member | 2 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ONCOTHERAPY SCIENCE, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Dojin Iyaku-Kako Co., Ltd.
Dojin Iyaku-Kako Co., Ltd. Pharmaceuticals: MajorHealth Technology Dojin Iyaku-Kaku Co., Ltd. is engaged in the development, production, and distribution of pharmaceutical products and pharmaceutical raw materials. The company was established in 1946 and is based in Tokyo, Japan. | Health Technology |
| Laboratoires OncoTherapy Science France SARL | |
Immunas Pharma, Inc.
Immunas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Immunas Pharma, Inc. develops anti-cancer antibody medicines. The company is based in Kawasaki, Japan. Immunas Pharma was acquired by OncoTherapy Science, Inc. on September 30, 2007 for $0.43 million. | Health Technology |
- Stock Market
- Insiders
- Masaharu Mori
- Experience
